Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BIIB
Tag: NASDAQ:BIIB
Analyst Activity – Leerink Swann Reiterates Market Perform on Biogen (NASDAQ:BIIB)
ME Staff
-
July 26, 2017
0
Biogen Inc. (NASDAQ:BIIB) reported earnings of $5.04 per share beating Walls...
ME Staff
-
July 25, 2017
0
BIOGEN INC. (NASDAQ:BIIB) Files An 8-K Results of Operations and Financial...
ME Staff 8-k
-
July 25, 2017
0
Insider Trading Activity Biogen Inc. (NASDAQ:BIIB) – EVP Sold 7,758 shares...
ME Staff
-
July 20, 2017
0
Analyst Activity – BMO Capital Markets Reiterates Hold on Biogen (NASDAQ:BIIB)
ME Staff
-
July 18, 2017
0
Analyst Activity – BMO Capital Markets Reiterates Hold on Biogen (NASDAQ:BIIB)
ME Staff
-
July 18, 2017
0
Biogen Inc. (NASDAQ:BIIB) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
June 13, 2017
0
Biogen Inc. (NASDAQ:BIIB) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
June 9, 2017
0
Teijin Pharma Grants Merck & Co., Inc. (NYSE:MRK) Exclusive Rights To...
Andy Parker
-
May 30, 2017
0
Celgene Corporation (NASDAQ:CELG) MS Drug Was Successful In Second Late-Stage Study
-
May 23, 2017
0
1
...
5
6
7
8
Page 6 of 8